Ghelli Luserna Di RorĂ , Andrea
Ghetti, Martina
Ledda, Lorenzo
Ferrari, Anna
Bocconcelli, Matteo
Padella, Antonella
Napolitano, Roberta
Fontana, Maria Chiara
Liverani, Chiara
Imbrogno, Enrica
Bochicchio, Maria Teresa
Paganelli, Matteo
Robustelli, Valentina
Sanogo, Seydou
Cerchione, Claudio
Fumagalli, Monica
Rondoni, Michela
Imovilli, Annalisa
Musuraca, Gerardo
Martinelli, Giovanni
Simonetti, Giorgia
Funding for this research was provided by:
Era-PerMEd (ERAPERMED2018-275)
Associazione Italiana per la Ricerca sul Cancro (19226)
Article History
Received: 14 April 2021
Accepted: 23 July 2021
First Online: 14 September 2021
Declarations
:
: All human samples were obtained with informed consent. The study was approved by Comitato Etico della Romagna (protocol 5244/2019) and was carried out in accordance with the principles laid down in the 1964 Declaration of Helsinki.
: All authors read and approved the final manuscript.
: GM has competing interests with Novartis, BMS, Roche, Pfizer, ARIAD, and MSD.